Cargando…
Research progress of in-situ gelling ophthalmic drug delivery system
Blindness and vision impairment are the most devastating global health problems resulting in a substantial economic and social burden. Delivery of drug to particular parts of the anterior or posterior segment has been a major challenge due to various protective barriers and elimination mechanisms as...
Autores principales: | Wu, Yumei, Liu, Yuanyuan, Li, Xinyue, Kebebe, Dereje, Zhang, Bing, Ren, Jing, Lu, Jun, Li, Jiawei, Du, Shouying, Liu, Zhidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032175/ https://www.ncbi.nlm.nih.gov/pubmed/32104434 http://dx.doi.org/10.1016/j.ajps.2018.04.008 |
Ejemplares similares
-
Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin
por: Vijaya, C., et al.
Publicado: (2011) -
Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers
por: Kebebe, Dereje, et al.
Publicado: (2018) -
Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer
por: Kebebe, Dereje, et al.
Publicado: (2019) -
Gellan gum–based in situ gelling ophthalmic nanosuspension of Posaconazole
por: Khare, Purva, et al.
Publicado: (2022) -
Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment
por: Huang, Rui, et al.
Publicado: (2018)